E-Ink News Daily

← Back to list

Millions of Americans are not taking their GLP-1 drugs as prescribed

A CDC study found that approximately 27 million U.S. adults used GLP-1 medications in 2025, with nearly half reporting modified use—including skipped doses and reduced amounts—primarily due to cost and access barriers. Younger users were disproportionately affected, and those using compounded GLP-1 drugs showed particularly high rates of off-prescription usage.

Background

GLP-1 receptor agonists like semaglutide and tirzepatide have surged in popularity for diabetes and weight loss treatment, leading to supply shortages and a rise in compounded alternatives from unregulated sources.

Source
Ars Technica
Published
Nov 14, 2026 at 05:59 AM
Score
6.0 / 10